The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas
Open accessAbstract
Alloxan and streptozotocin are widely used to induce experimental diabetes in animals. The mechanism of their action in B cells of the pancreas has been intensively investigated and now is quite well understood. The cytotoxic action of both these diabetogenic agents is mediated by reactive oxygen species, however, the source of their generation is different in the case of alloxan and streptozotocin. Alloxan and the product of its reduction, dialuric acid, establish a redox cycle with the formation of superoxide radicals. These radicals undergo dismutation to hydrogen peroxide. Thereafter highly reactive hydroxyl radicals are formed by the Fenton reaction. The action of reactive oxygen species with a simultaneous massive increase in cytosolic calcium concentration causes rapid destruction of B cells. Streptozotocin enters the B cell via a glucose transporter (GLUT2) and causes alkylation of DNA. DNA damage induces activation of poly ADP-ribosylation, a process that is more important for the diabetogenicity of streptozotocin than DNA damage itself. Poly ADP-ribosylation leads to depletion of cellular NAD+ and ATP. Enhanced ATP dephosphorylation after streptozotocin treatment supplies a substrate for xanthine oxidase resulting in the formation of superoxide radicals. Consequently, hydrogen peroxide and hydroxyl radicals are also generated. Furthermore, streptozotocin liberates toxic amounts of nitric oxide that inhibits aconitase activity and participates in DNA damage. As a result of the streptozotocin action, B cells undergo the destruction by necrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tiedge, M., Lortz, S., Drinkgern, J., & Lenzen, S. (1997) · Diabetes · doi:10.2337/diab.46.11.1733 · Cited by 1,208
Yamamoto, H., Uchigata, Y., & Okamoto, H. (1981) · Nature · doi:10.1038/294284a0 · Cited by 526
Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin
Elsner, M., Guldbakke, B., Tiedge, M., Munday, R., & Lenzen, S. (2000) · Diabetologia · doi:10.1007/s001250051564 · Cited by 369
Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes
Pieper, A. A., Brat, D. J., Krug, D. K., Watkins, C. C., Gupta, A., Blackshaw, S., Verma, A., Wang, Z.-Q., & Snyder, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3059 · Cited by 298
Determinants of the selective toxicity of alloxan to the pancreatic B cell.
Malaisse, W. J., Malaisse-Lagae, F., Sener, A., & Pipeleers, D. G. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.3.927 · Cited by 282
Eizirik, D. L., Pipeleers, D. G., Ling, Z., Welsh, N., Hellerström, C., & Andersson, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9253 · Cited by 261
Alloxan: history and mechanism of action
Lenzen, S., & Panten, U. (1988) · Diabetologia · doi:10.1007/bf02341500 · Cited by 253
Alloxan-induced diabetes—evidence for hydroxyl radical as a cytotoxic intermediate
Heikkila, R. E., Winston, B., Cohen, G., & Barden, H. (1976) · Biochemical Pharmacology · doi:10.1016/0006-2952(76)90502-5 · Cited by 243
Wang, Z., & Gleichmann, H. (1998) · Diabetes · doi:10.2337/diab.47.1.50 · Cited by 243
NECROSIS OF ISLETS OF LANGERHANS PRODUCED EXPERIMENTALLY
SHAWDUNN, J. (1943) · The Lancet · doi:10.1016/s0140-6736(00)42072-6 · Cited by 242
Cited by
The mechanisms of alloxan- and streptozotocin-induced diabetes
Lenzen, S. (2008) · Diabetologia · doi:10.1007/s00125-007-0886-7 · Cited by 2,290
The use of animal models in diabetes research
King, A. J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01911.x · Cited by 1,303
Alzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158
COSKUN, O., KANTER, M., KORKMAZ, A., & OTER, S. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2004.06.002 · Cited by 814
Pomegranate and its many functional components as related to human health: a review
Viuda‐Martos, M., Fernández‐López, J., & Pérez‐Álvarez, J. A. (2010) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/j.1541-4337.2010.00131.x · Cited by 768
Ferdinandy, P., Schulz, R., & Baxter, G. F. (2007) · Pharmacological Reviews · doi:10.1124/pr.107.06002 · Cited by 744
Bala, N., Saha, S., Chakraborty, M., Maiti, M., Das, S., Basu, R., & Nandy, P. (2015) · RSC Advances · doi:10.1039/c4ra12784f · Cited by 743
Strategy for Treatment of Infected Diabetic Foot Ulcers
Chang, M., & Nguyen, T. T. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00864 · Cited by 712
Zhang, M., Lv, X.-Y., Li, J., Xu, Z.-G., & Chen, L. (2008) · Journal of Diabetes Research · doi:10.1155/2008/704045 · Cited by 667
Antidiabetic effects of quercetin in streptozocin-induced diabetic rats
Vessal, M., Hemmati, M., & Vasei, M. (2003) · Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · doi:10.1016/s1532-0456(03)00140-6 · Cited by 624
Deeds, M. C., Anderson, J. M., Armstrong, A. S., Gastineau, D. A., Hiddinga, H. J., Jahangir, A., Eberhardt, N. L., & Kudva, Y. C. (2011) · Laboratory Animals · doi:10.1258/la.2010.010090 · Cited by 605
Modeling type 2 diabetes in rats using high fat diet and streptozotocin
Skovsø, S. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12235 · Cited by 596
Kamalakkannan, N., & Prince, P. S. M. (2006) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2006.pto_241.x · Cited by 522
Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer’s disease
Lester-Coll, N., Rivera, E. J., Soscia, S. J., Doiron, K., Wands, J. R., & de la Monte, S. M. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9102 · Cited by 467
Brain metabolic dysfunction at the core of Alzheimer's disease
de la Monte, S. M., & Tong, M. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.012 · Cited by 461
Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimers Disease
M. de la Monte, S. (2012) · Current Alzheimer Research · doi:10.2174/156720512799015037 · Cited by 448
Streptozotocin–nicotinamide-induced diabetes in the rat. Characteristics of the experimental model
Szkudelski, T. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.011372 · Cited by 436
Self-citationGoyal, S. N., Reddy, N. M., Patil, K. R., Nakhate, K. T., Ojha, S., Patil, C. R., & Agrawal, Y. O. (2016) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.032 · Cited by 419
Regulation of pancreatic beta-cell mass
Bouwens, L., & Rooman, I. (2005) · Physiological Reviews · doi:10.1152/physrev.00025.2004 · Cited by 411
Rodent Models for Metabolic Syndrome Research
Panchal, S. K., & Brown, L. (2011) · BioMed Research International · doi:10.1155/2011/351982 · Cited by 408
Ezuruike, U. F., & Prieto, J. M. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.05.055 · Cited by 401
Insulin resistance and Alzheimer's disease
De La Monte, S. M. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.8.475 · Cited by 392
Ighodaro, O. M., Adeosun, A. M., & Akinloye, O. A. (2017) · Medicina · doi:10.1016/j.medici.2018.02.001 · Cited by 385
Grünblatt, E., Salkovic‐Petrisic, M., Osmanovic, J., Riederer, P., & Hoyer, S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04368.x · Cited by 374
Mahmoud, A. M., Ashour, M. B., Abdel-Moneim, A., & Ahmed, O. M. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2012.06.001 · Cited by 374
Gheibi, S., Kashfi, K., & Ghasemi, A. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.08.098 · Cited by 356
Resveratrol and diabetes: from animal to human studies
Szkudelski, T., & Szkudelska, K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.013 · Cited by 354
Self-citationTreviño, S., Díaz, A., Sánchez-Lara, E., Sanchez-Gaytan, B. L., Perez-Aguilar, J. M., & González-Vergara, E. (2019) · Biological Trace Element Research · doi:10.1007/s12011-018-1540-6 · Cited by 354
Fujita, H., Morii, T., Fujishima, H., Sato, T., Shimizu, T., Hosoba, M., Tsukiyama, K., Narita, T., Takahashi, T., Drucker, D. J., et al. (2014) · Kidney International · doi:10.1038/ki.2013.427 · Cited by 336
de la Monte, S. M., Tong, M., Lester-Coll, N., Plater, Jr., & Wands, J. R. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-10113 · Cited by 325
Adisakwattana, S. (2017) · Nutrients · doi:10.3390/nu9020163 · Cited by 311
Animal models to test drugs with potential antidiabetic activity
Fröde, T. S., & Medeiros, Y. S. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.10.038 · Cited by 296
Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes
Wilson, R. D., & Islam, M. S. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70739-9 · Cited by 289
Chen, Y., Liang, Z., Blanchard, J., Dai, C.-L., Sun, S., Lee, M. H., Grundke-Iqbal, I., Iqbal, K., Liu, F., & Gong, C.-X. (2013) · Molecular Neurobiology · doi:10.1007/s12035-012-8375-5 · Cited by 288
Solinas, G., Naugler, W., Galimi, F., Lee, M.-S., & Karin, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607626103 · Cited by 284
Gainza, G., Villullas, S., Pedraz, J. L., Hernandez, R. M., & Igartua, M. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.03.002 · Cited by 275
Streptozotocin-nicotinamide-induced rat model of type 2 diabetes (review)
Ghasemi, A., Khalifi, S., & Jedi, S. (2014) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.101.2014.4.2 · Cited by 274
Salkovic-Petrisic, M., Knezovic, A., Hoyer, S., & Riederer, P. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-012-0877-9 · Cited by 272
Experimental diabetes induced by alloxan and streptozotocin: The current state of the art
Radenković, M., Stojanović, M., & Prostran, M. (2016) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2015.11.004 · Cited by 270
Bone Loss and Increased Bone Adiposity in Spontaneous and Pharmacologically Induced Diabetic Mice
Botolin, S., & McCabe, L. R. (2007) · Endocrinology · doi:10.1210/en.2006-1006 · Cited by 266
Noninvasive in vivo imaging of pancreatic islet cell biology
Speier, S., Nyqvist, D., Cabrera, O., Yu, J., Molano, R. D., Pileggi, A., Moede, T., Köhler, M., Wilbertz, J., Leibiger, B., et al. (2008) · Nature Medicine · doi:10.1038/nm1701 · Cited by 266
Experimental animal models for diabetes and its related complications—a review
Kottaisamy, C. P. D., Raj, D. S., Prasanth Kumar, V., & Sankaran, U. (2021) · Laboratory Animal Research · doi:10.1186/s42826-021-00101-4 · Cited by 263
Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?
Correia, S. C., Santos, R. X., Perry, G., Zhu, X., Moreira, P. I., & Smith, M. A. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.01.001 · Cited by 212
Pal, P. B., Sinha, K., & Sil, P. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107220 · Cited by 185
Large animal models of cardiovascular disease
Tsang, H. G., Rashdan, N. A., Whitelaw, C. B. A., Corcoran, B. M., Summers, K. M., & MacRae, V. E. (2016) · Cell Biochemistry and Function · doi:10.1002/cbf.3173 · Cited by 154
Kiba, T. (2004) · Pancreas · doi:10.1097/00006676-200408000-00019 · Cited by 126
Rosemary Extract as a Potential Anti-Hyperglycemic Agent: Current Evidence and Future Perspectives
Naimi, M., Vlavcheski, F., Shamshoum, H., & Tsiani, E. (2017) · Nutrients · doi:10.3390/nu9090968 · Cited by 119
Advancements and challenges in generating accurate animal models of gestational diabetes mellitus
Pasek, R. C., & Gannon, M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00425.2013 · Cited by 90
Punaro, G. R., Maciel, F. R., Rodrigues, A. M., Rogero, M. M., Bogsan, C. S. B., Oliveira, M. N., Ihara, S. S. M., Araujo, S. R. R., Sanches, T. R. C., Andrade, L. C., et al. (2014) · Nitric Oxide · doi:10.1016/j.niox.2013.12.012 · Cited by 76
Effect of Withania somnifera on Insulin Sensitivity in Non‐Insulin‐Dependent Diabetes Mellitus Rats
Anwer, T., Sharma, M., Pillai, K. K., & Iqbal, M. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00223.x · Cited by 75
Song, Y., Liu, W., Tang, K., Zang, J., Li, D., & Gao, H. (2020) · Journal of Diabetes Research · doi:10.1155/2020/9481720 · Cited by 67
Lechuga-Sancho, A. M., Arroba, A. I., Frago, L. M., García-Cáceres, C., de Célix, A. D.-R., Argente, J., & Chowen, J. A. (2006) · Endocrinology · doi:10.1210/en.2006-0766 · Cited by 64
Insights on the Health Benefits of the Bioactive Compounds of Coffee Silverskin Extract
Fernandez-Gomez, B., Lezama, A., Amigo-Benavent, M., Ullate, M., Herrero, M., Martín, M. Á., Mesa, M. D., & del Castillo, M. D. (2016) · Journal of Functional Foods · doi:10.1016/j.jff.2016.06.001 · Cited by 58
Antidiabetic potentials of ethanolic extract of Aristolochia ringens (Vahl.) roots
Sulyman, A. O., Akolade, J. O., Sabiu, S. A., Aladodo, R. A., & Muritala, H. F. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.02.002 · Cited by 55
Renal mitochondrial impairment is attenuated by AT 1 blockade in experimental Type I diabetes
de Cavanagh, E. M. V., Ferder, L., Toblli, J. E., Piotrkowski, B., Stella, I., Fraga, C. G., & Inserra, F. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00926.2007 · Cited by 54
Irondi, E. A., Oboh, G., & Akindahunsi, A. A. (2016) · Food Science & Nutrition · doi:10.1002/fsn3.348 · Cited by 53
Antidiabetic activity of mango peel extract and mangiferin in alloxan-induced diabetic rats
Mistry, J., Biswas, M., Sarkar, S., & Ghosh, S. (2023) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-023-00472-6 · Cited by 48
Han, J., Yang, N., Zhang, F., Zhang, C., Liang, F., Xie, W., & Chen, W. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.05.016 · Cited by 39
Therapeutic Potentials of Microalgae and Their Bioactive Compounds on Diabetes Mellitus
Tamel Selvan, K., Goon, J. A., Makpol, S., & Tan, J. K. (2023) · Marine Drugs · doi:10.3390/md21090462 · Cited by 32
Rajamohan, T., & Renjith, R. (2012) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.100368 · Cited by 22
Mallek, A., Movassat, J., Ameddah, S., Liu, J., Semiane, N., Khalkhal, A., & Dahmani, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.070 · Cited by 20
HYPOGLYCEMIC AND HYPOLIPIDEMIC EFFECTS OF ANNONA MURICATA L. LEAF ETHANOL EXTRACT
Sovia, E., Ratwita, W., Wijayanti, D., & Novianty, D. R. (2017) · International Journal of Pharmacy and Pharmaceutical Sciences · doi:10.22159/ijpps.2017v9i3.16402 · Cited by 14
Neuroprotective substances: Are they able to protect the pancreatic beta-cells too?
Ostrovskaya, R. U., & Ivanov, S. V. (2022) · Endocrine, Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220303162844 · Cited by 13
Metadata
- Authors
- Szkudelski, T.
- Venue
- Physiological Research
- Published
- 2001
- Volume
- 50
- Issue
- 6
- Pages
- 537-546
- ISSN
- 0862-8408 (ISSN-L)
- 1802-9973
- OpenAlex
- W2108250096
- Cited by
- 2,876
- References
- 44
- FWCI
- 9.94
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.